Revance Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 8.60 M | $26.14 M | -1.49% | 8.25% |
| BERYL CAPITAL MANAGEMENT LLC | 02/14/2025 | 5.94 M | $18.04 M | 100.00% | 5.70% |
| VANGUARD GROUP INC | 02/11/2025 | 5.63 M | $17.10 M | -1.89% | 5.40% |
| 02/12/2025 | 5.10 M | $15.50 M | 603.45% | 4.89% | |
| FIL LTD | 02/13/2025 | 4.20 M | $12.76 M | 0.08% | 4.03% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 3.50 M | $10.63 M | 7.26% | 3.36% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 3.16 M | $9.62 M | 37.03% | 3.04% |
| METEORA CAPITAL, LLC | 02/14/2025 | 2.87 M | $8.72 M | 100.00% | 2.75% |
| MAGNETAR FINANCIAL LLC | 02/11/2025 | 2.56 M | $7.77 M | 2.25% | 2.45% |
| STATE STREET CORP | 02/14/2025 | 2.44 M | $7.41 M | 0.21% | 2.34% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 02/07/2025 | 2.35 M | $7.14 M | -43.55% | 2.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.30 M | $6.99 M | 0.35% | 2.20% |
| GLAZER CAPITAL, LLC | 02/14/2025 | 1.95 M | $5.93 M | 100.00% | 1.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 1.87 M | $5.67 M | 100.00% | 1.79% |
| NEWTYN MANAGEMENT, LLC | 02/14/2025 | 1.81 M | $5.50 M | 100.00% | 1.74% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.65 M | $5.03 M | 57.49% | 1.59% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.55 M | $4.72 M | 949.57% | 1.49% |
| UBS GROUP AG | 02/14/2025 | 1.48 M | $4.51 M | 134.45% | 1.42% |
| AQR ARBITRAGE LLC | 02/14/2025 | 1.41 M | $4.30 M | 0.00% | 1.36% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 1.37 M | $4.16 M | -29.23% | 1.31% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 1.33 M | $4.04 M | -29.75% | 1.27% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.30 M | $3.95 M | 867.96% | 1.25% |
| GABELLI FUNDS LLC | 02/13/2025 | 1.26 M | $3.84 M | 15.70% | 1.21% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 1.16 M | $3.53 M | -75.73% | 1.11% |
| 03/18/2025 | 1.14 M | $3.47 M | 100.00% | 1.09% | |
| GABELLI & CO INVESTMENT ADVISERS, INC. | 02/13/2025 | 1.06 M | $3.22 M | 26.04% | 1.02% |
| NORTHERN TRUST CORP | 02/14/2025 | 991.04 K | $3.01 M | 2.72% | 0.95% |
| MORGAN STANLEY | 05/15/2025 | 893.69 K | $2.72 M | 3.06% | 0.86% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 812.93 K | $2.47 M | -30.12% | 0.78% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 797.30 K | $2.42 M | 0.82% | 0.77% |
| WATER ISLAND CAPITAL LLC | 02/13/2025 | 722.23 K | $2.20 M | -69.67% | 0.69% |
| RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 678.54 K | $2.06 M | -7.07% | 0.65% |
| SLOTNIK CAPITAL, LLC | 02/12/2025 | 671.61 K | $2.04 M | 100.00% | 0.64% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 02/14/2025 | 551.22 K | $1.68 M | 100.00% | 0.53% |
| FNY INVESTMENT ADVISERS, LLC | 01/13/2025 | 477.82 K | $1.45 M | 160.39% | 0.46% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 02/13/2025 | 457.09 K | $1.39 M | 0.00% | 0.44% |
| MAN GROUP PLC | 02/14/2025 | 443.54 K | $1.35 M | 47.85% | 0.43% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 423.19 K | $1.29 M | -7.06% | 0.41% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 414.31 K | $1.26 M | 176.21% | 0.40% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 411.52 K | $1.25 M | -7.74% | 0.39% |
| CITADEL ADVISORS LLC | 02/14/2025 | 407.80 K | $1.24 M | 775.11% | 0.39% |
| BARCLAYS PLC | 02/13/2025 | 402.69 K | $1.23 M | 132.29% | 0.39% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 400.00 K | $1.22 M | 4,900.00% | 0.38% |
| 02/14/2025 | 360.00 K | $1.09 M | 100.00% | 0.35% | |
| VAZIRANI ASSET MANAGEMENT LLC | 02/14/2025 | 350.00 K | $1.06 M | 250.00% | 0.34% |
| LMR PARTNERS LLP | 02/14/2025 | 347.21 K | $1.06 M | -84.53% | 0.33% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 307.76 K | $935.60 K | -5.68% | 0.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 303.07 K | $921.34 K | 435.17% | 0.29% |
| CANDRIAM S.C.A. | 02/07/2025 | 299.04 K | $909.08 K | 100.00% | 0.29% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 297.46 K | $904.00 K | 137.97% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Revance Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 210 institutional investors and hedge funds held shares of Revance Therapeutics, Inc.. The most heavily invested institutionals were:
Amundi: 0
MARSHALL WACE, LLP: 0
Vestcor Inc: 0
Alpine Global Management, LLC: 0
SIMPLEX TRADING, LLC: 0
DEUTSCHE BANK AG\: 0
78.32% of Revance Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.39 M shares in the last 24 months. This purchase volume represents approximately $63.47 M in transactions.